Barry Bachenheimer Social Worker Pllc Social Worker - Clinical Medicare: Medicare Enrolled Practice Location: 5 Fairlawn Dr, Washingtonville, NY 10992 Phone: 845-496-6029 |
Live Well Individual And Family Counseling Service, Lcsw, Llc Social Worker - Clinical Medicare: Not Enrolled in Medicare Practice Location: 90 E Main St Ste 201, Washingtonville, NY 10992 Phone: 845-614-4003 Fax: 845-614-0946 |
Claudio Morel Social Worker Medicare: Not Enrolled in Medicare Practice Location: 49 Ballard Pond Dr, Washingtonville, NY 10992 Phone: 917-584-5236 |
News Archive
A single dose of adult donor stem cells given to animals that have neurological damage similar to that experienced by adults with a stroke or newborns with cerebral palsy can significantly enhance recovery from these types of injuries, researchers say.
Ben-Gurion University of the Negev Professor Varda Shoshan-Barmatz has been awarded a three-year, $600,000 grant from the U.S. Leukemia & Lymphoma Society to develop target-specific, anti-cancer drugs.
Even at a hospital recognized for managing seriously ill patients, a systematic assessment of clinical measures associated with end-of-life care identified opportunities to improve treatment for those dying in the hospital, according to a report in the June 28 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC), a clinical-stage biotechnology company that is developing immune-based therapies for the treatment of brain and other cancers, today announced that it will be presenting today, at the Annual Meeting of the Congress of Neurological Surgeons in New Orleans, Louisiana at 3:15pm central time, data from its Phase I clinical trial investigating the role that its ICT-107 vaccine may play in increasing patient survival and inhibiting tumor progression in patients with glioblastoma, the most common and most aggressive type of primary brain tumor.
Pharma major, Lupin Ltd., announced today that its subsidiary, Lupin Pharmaceuticals Inc. (collectively, Lupin) has launched its Fenofibrate Tablets, 48 mg and 145 mg strengths in the United States. Lupin had earlier received final approval for the same from the US Food and Drug Administration (FDA).
› Verified 2 days ago